Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 300

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

Open access
Paiva, Bruno, Gutiérrez, Norma C., Rosiñol, Laura, Vídriales, María-Belén, Montalbán, María-Ángeles, Martínez-López, Joaquín, Mateos, María-Victoria, Cibeira, María-Teresa, Cordón, Lourdes, Oriol, Albert, Terol, María-José, Echeveste, María-Asunción, de Paz, Raquel, de Arriba, Felipe, Palomera, Luis, de la Rubia, Javier, Díaz-Mediavilla, Joaquín, Sureda, Anna, Gorosquieta, Ana, Alegre, Adrian, Martin, Alejandro, Hernández, Miguel T., Lahuerta, Juan-José, Bladé, Joan, San Miguel, Jesús F.·2012·Blood

Abstract

The achievement of complete response (CR) after high-dose therapy/autologous stem cell transplantation (HDT/ASCT) is a surrogate for prolonged survival in multiple myeloma; however, patients who lose their CR status within 1 year of HDT/ASCT (unsustained CR) have poor prognosis. Thus, the identification of these patients is highly relevant. Here, we investigate which prognostic markers can predict unsustained CR in a series of 241 patients in CR at day +100 after HDT/ASCT who were enrolled in the Spanish GEM2000 (n = 140) and GEM2005 < 65y (n = 101) trials. Twenty-nine (12%) of the 241 patients showed unsustained CR and a dismal outcome (median overall survival 39 months). The presence of baseline high-risk cytogenetics by FISH (hazard ratio 17.3; P = .002) and persistent minimal residual disease by multiparameter flow cytometry at day +100 after HDT/ASCT (hazard ratio 8.0; P = .005) were the only independent factors that predicted unsustained CR. Thus, these 2 parameters may help to identify patients in CR at risk of early progression after HDT/ASCT in whom novel treatments should be investigated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2011-07-370460

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 300

Metadata

Authors
Paiva, B., Gutiérrez, N. C., Rosiñol, L., Vídriales, M.-B., Montalbán, M.-Á., Martínez-López, J., Mateos, M.-V., Cibeira, M.-T., Cordón, L., Oriol, A., Terol, M.-J., Echeveste, M.-A., de Paz, R., de Arriba, F., Palomera, L., de la Rubia, J., Díaz-Mediavilla, J., Sureda, A., Gorosquieta, A., Alegre, A., Martin, A., Hernández, M. T., Lahuerta, J.-J., Bladé, J., & San Miguel, J. F.
Venue
Blood
Published
2012-01-19
Volume
119
Issue
3
Pages
687-691
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2028286166
Cited by
300
References
22
FWCI
13.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma. https://app.cochat.ai/papers/10.1182/blood-2011-07-370460
The paper
Paiva, B., Gutiérrez, N. C., Rosiñol, L., Vídriales, M.-B., Montalbán, M.-Á., Martínez-López, J., Mateos, M.-V., Cibeira, M.-T., Cordón, L., Oriol, A., Terol, M.-J., Echeveste, M.-A., de Paz, R., de Arriba, F., Palomera, L., de la Rubia, J., Díaz-Mediavilla, J., Sureda, A., Gorosquieta, A., . . . San Miguel, J. F. (2012). High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma. Blood. https://doi.org/10.1182/blood-2011-07-370460

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.